In our study, the HS subgroup exhibited a significantly worse prognosis (Fig. 2e), significantly higher Gleason score, and expressed the highest level of serum PSA (Fig. 3c), indicating the highest malignancy in HS patients. The gene discussed is KLK3; the disease is histiocytic sarcoma.